This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Nov;59(11):1454-5.

doi: 10.1136/gut.2010.220954.

Optimal treatment of metastatic pancreatic cancer

David Cunningham¹, Irene Chong

Affiliations

PMID: 20947879
DOI: 10.1136/gut.2010.220954

Comment

Optimal treatment of metastatic pancreatic cancer

David Cunningham et al. Gut. 2010 Nov.

. 2010 Nov;59(11):1454-5.

doi: 10.1136/gut.2010.220954.

Authors

David Cunningham¹, Irene Chong

Affiliation

¹ The Royal Marsden Hospital, Surrey, SM2 5PT, UK. david.cunningham@rmh.nhs.uk

PMID: 20947879
DOI: 10.1136/gut.2010.220954

No abstract available

PubMed Disclaimer

Comment on

Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301).
Dahan L, Bonnetain F, Ychou M, Mitry E, Gasmi M, Raoul JL, Cattan S, Phelip JM, Hammel P, Chauffert B, Michel P, Legoux JL, Rougier P, Bedenne L, Seitz JF; Fédération Francophone de Cancérologie Digestive. Dahan L, et al. Gut. 2010 Nov;59(11):1527-34. doi: 10.1136/gut.2010.216135. Gut. 2010. PMID: 20947887 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information